Icon

BORTEZOMIB - (3.5MG/3.5ML, 3.5MG/1.4ML)

BORTEZOMIB None
3.5MG/3.5ML, 3.5MG/1.4ML
Less Than $1000 mn
None None
None None
None None
BORTEZOMIB is a proteasome inhibitor indicated for: • treatment of adult patients with multiple myeloma • treatment of adult patients with mantle cell lymphoma.
Yes
BORTEZOMIB Patent 1 Patent 2 Patent 3
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.